Cargando…

Serum sodium and chloride are inversely associated with dyskinesia in Parkinson's disease patients

OBJECTIVE: We aim to report and evaluate the associations between serum sodium and chloride and dyskinesia in patients with Parkinson's disease. One hundred and two patients with Parkinson's disease were enrolled in this study. METHODS: Patients’ serum electrolytes including sodium, calciu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Cheng‐jie, Zhong, Chong‐ke, Yang, Yong, Yang, Ya‐ping, Wang, Fen, Chen, Jing, Zhang, Jin‐ru, Zhang, Hui‐jun, Jin, Hong, Xu, Ling‐li, Huang, Juan‐ying, Liu, Chun‐Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745246/ https://www.ncbi.nlm.nih.gov/pubmed/29299386 http://dx.doi.org/10.1002/brb3.867

Ejemplares similares

Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson’s disease
por: Li, Kai, et al.
Publicado: (2020)

Dysfunction in superior frontal gyrus associated with diphasic dyskinesia in Parkinson’s disease
por: Shen, Yu-Ting, et al.
Publicado: (2020)

PESISTENT PARKINSONISM AND TARDIVE DYSKINESIA
por: Shaji, K.S., et al.
Publicado: (1995)

Dyskinesia in Parkinson's Disease Therapy
por: Carta, Anna Rosa, et al.
Publicado: (2012)

Multivariable clinical-genetic model for predicting dyskinesia in early-onset Parkinson’s disease
por: Chen, Yong-Ping, et al.
Publicado: (2021)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
por: Soares, Nayron Medeiros, et al.
Publicado: (2023)

Rhabdomyolysis Related to Dyskinesia in Parkinson’s Disease
por: Bektaş, Hesna, et al.
Publicado: (2014)

Parkinson’s disease: carbidopa, nausea, and dyskinesia
por: Hinz, Marty, et al.
Publicado: (2014)

Surgical Treatment of Dyskinesia in Parkinson’s Disease
por: Munhoz, Renato P., et al.
Publicado: (2014)

The increased gray matter volumes of precentral gyri in Parkinson's disease patients with diphasic dyskinesia
por: Zhi, Yan, et al.
Publicado: (2019)

A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA
por: Chadda, R., et al.
Publicado: (1986)

White matter hyperintensities and risk of levodopa‐induced dyskinesia in Parkinson’s disease
por: Chung, Seok Jong, et al.
Publicado: (2020)

Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications
por: Liu, Xing, et al.
Publicado: (2015)

High PSQI score is associated with the development of dyskinesia in Parkinson’s disease
por: Tang, Xiaohui, et al.
Publicado: (2022)

Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
por: Yoo, Han Soo, et al.
Publicado: (2019)

Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease
por: Fan, Qian-Ya, et al.
Publicado: (2022)

Chloride of Sodium
Publicado: (1871)

Chloride of Sodium
por: Means, A.
Publicado: (1868)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
por: Song, Tianbin, et al.
Publicado: (2021)

An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease
por: Kong, Min, et al.
Publicado: (2017)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
por: Piedad, John C. P., et al.
Publicado: (2012)

“Cueing” for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Schaeffer, Eva, et al.
Publicado: (2016)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
Publicado: (2021)

Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
por: Yang, Changwei, et al.
Publicado: (2020)

Substantia nigra hyperechogenicity in Parkinson disease patients with leucine-rich repeat kinase 2 variants in the Chinese Han population
por: Li, Kai, et al.
Publicado: (2020)

Pallidal Structural Changes Related to Levodopa-induced Dyskinesia in Parkinson's Disease
por: Youn, Jinyoung, et al.
Publicado: (2022)

Coupling effects of human serum albumin and sodium chloride on biological desiccation patterns
por: Wang, Jihong, et al.
Publicado: (2023)

Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson’s disease
por: Cui, Guiyun, et al.
Publicado: (2013)

β-arrestin2 alleviates L-dopa–induced dyskinesia via lower D1R activity in Parkinson’s rats
por: Zhang, Xing-Ru, et al.
Publicado: (2019)

Transport and Electrochemical Characteristics of CJMCED Homogeneous Cation Exchange Membranes in Sodium Chloride, Calcium Chloride, and Sodium Sulfate Solutions
por: Sarapulova, Veronika, et al.
Publicado: (2020)

Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
por: Pahwa, Rajesh, et al.
Publicado: (2022)

Effect of Subthalamic Deep Brain Stimulation on Levodopa-Induced Dyskinesia in Parkinson's Disease
por: Kim, Ji Hee, et al.
Publicado: (2015)

Chloride of Iron and Chloride of Sodium as a Hæmostatic
Publicado: (1863)

The Uses of the Chloride of Sodium
por: Herrick, W. B.
Publicado: (1851)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas, Panagiotis, et al.
Publicado: (2013)

Future Scenarios for Levodopa-Induced Dyskinesias in Parkinson’s Disease
por: Cerasa, Antonio, et al.
Publicado: (2015)

Surgical Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
por: Krishnan, Syam, et al.
Publicado: (2017)

Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China
por: Zhou, Xun, et al.
Publicado: (2019)

Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease
por: Athulya, RT, et al.
Publicado: (2020)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mpjaoqv1pricpld3j4dqku1avf